nominally significantP = 0.012
In this set, we identified nominally significant association between a rare haplogroup, E1b1b1c, and prostate cancer in stage I ( P = 0.012, OR = 0.51; 95% confidence interval 0.30–0.87).
In this set, we identified nominally significant association between a rare haplogroup, E1b1b1c, and prostate cancer in stage I ( P = 0.012, OR = 0.51; 95% confidence interval 0.30–0.87).